Rocket pharmaceuticals to participate in the 7th annual evercore healthconx conference

Cranbury, n.j.--(business wire)--rocket pharmaceuticals, inc. (nasdaq: rckt), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the company will participate in the 7th annual evercore healthconx conference in miami, florida. gaurav shah, m.d., chief executive officer, will take part in a fireside chat on tuesday, december 3, at 1:45 p.m. et and host investor meetings throughout.
EVR Ratings Summary
EVR Quant Ranking